
|Articles|January 13, 2012
Reimbursement: Too Low?
Complaints about PBM reimbursement are industry-wide. What can be done?
Advertisement
For years, I have heard pharmacists complain that their PBM reimbursement for filling a prescription was too low. My response was always to ask the question, “Why do you agree to terms that in your opinion are too low?” I have heard many excuses but until Walgreens decided to break with Express Script last year I had not seen many pharmacies not sign a contract.
I think what Walgreens did took real leadership with that decision. In the end, I think not only will that decision be good for pharmacy as a whole but also good for Walgreens in the long run. What do you think?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































